- Home
- MKDW vs ESLA Comparison
MKDW vs ESLA Comparison
Compare MKDW & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- ESLA
- Stock Information
- Founded
- MKDW 2006
- ESLA 2021
- Country
- MKDW Taiwan
- ESLA United States
- Employees
- MKDW N/A
- ESLA N/A
- Industry
- MKDW
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKDW
- ESLA Health Care
- Exchange
- MKDW NYSE
- ESLA Nasdaq
- Market Cap
- MKDW 40.2M
- ESLA 35.5M
- IPO Year
- MKDW N/A
- ESLA N/A
- Fundamental
- Price
- MKDW $0.32
- ESLA $1.07
- Analyst Decision
- MKDW
- ESLA Strong Buy
- Analyst Count
- MKDW 0
- ESLA 1
- Target Price
- MKDW N/A
- ESLA $16.00
- AVG Volume (30 Days)
- MKDW 5.1M
- ESLA 518.6K
- Earning Date
- MKDW 07-21-2025
- ESLA 06-17-2025
- Dividend Yield
- MKDW N/A
- ESLA N/A
- EPS Growth
- MKDW N/A
- ESLA N/A
- EPS
- MKDW N/A
- ESLA N/A
- Revenue
- MKDW $3,670,722.00
- ESLA N/A
- Revenue This Year
- MKDW N/A
- ESLA $101.09
- Revenue Next Year
- MKDW N/A
- ESLA N/A
- P/E Ratio
- MKDW N/A
- ESLA N/A
- Revenue Growth
- MKDW 16.40
- ESLA N/A
- 52 Week Low
- MKDW $0.17
- ESLA $0.63
- 52 Week High
- MKDW $5.52
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- ESLA 55.18
- Support Level
- MKDW N/A
- ESLA $0.78
- Resistance Level
- MKDW N/A
- ESLA $1.18
- Average True Range (ATR)
- MKDW 0.00
- ESLA 0.10
- MACD
- MKDW 0.00
- ESLA 0.00
- Stochastic Oscillator
- MKDW 0.00
- ESLA 71.28
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.